Bild aus dem Geschäftsbericht 2007:
Image du rapport annuel 2007:
Picture of the annual report 2007:
STRATEGY GALENICA GROUP
STRATEGY
_Since 1 September 1995, Galenica’s Board of Directors has pursued a transformation strategy designed to create an entity that is totally different from the original Swiss pharmacy wholesaler. Because of the ongoing radical changes affecting the health care markets, the Group’s strategy is updated where appropriate but remains fundamentally true to the underlying concept of progressive development. The Group focuses on two strategic areas:
Specialty Pharma
_The central element of Specialty Pharma is the fully integrated specialty pharma group Vifor Pharma. Vifor Pharma researches, develops, produces and markets pharmaceutical products and solutions that significantly improve the quality of life of patients throughout the world.
Swiss HealthCare Services
_The focus of Galenica’s second strategic area, Swiss HealthCare Services, is a unique integrated business model for the Swiss health care market that combines products from the Pharma business sector, logistics services, information management and several different pharmacy formats.
